213 related articles for article (PubMed ID: 34461123)
1. Endocrine disruptors: Challenges and future directions in epidemiologic research.
Ho V; Pelland-St-Pierre L; Gravel S; Bouchard MF; Verner MA; Labrèche F
Environ Res; 2022 Mar; 204(Pt A):111969. PubMed ID: 34461123
[TBL] [Abstract][Full Text] [Related]
2. Methodological issues in human studies of endocrine disrupting chemicals.
Lee DH; Jacobs DR
Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
[TBL] [Abstract][Full Text] [Related]
3. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
Wan MLY; Co VA; El-Nezami H
Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
[TBL] [Abstract][Full Text] [Related]
4. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons.
Lee DH; Jacobs DR
J Clin Epidemiol; 2019 Mar; 107():107-115. PubMed ID: 30543909
[TBL] [Abstract][Full Text] [Related]
5. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
[TBL] [Abstract][Full Text] [Related]
6. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
[TBL] [Abstract][Full Text] [Related]
7. Why endocrine disrupting chemicals (EDCs) challenge traditional risk assessment and how to respond.
Futran Fuhrman V; Tal A; Arnon S
J Hazard Mater; 2015 Apr; 286():589-611. PubMed ID: 25646754
[TBL] [Abstract][Full Text] [Related]
8. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
Vandenberg LN; Ågerstrand M; Beronius A; Beausoleil C; Bergman Å; Bero LA; Bornehag CG; Boyer CS; Cooper GS; Cotgreave I; Gee D; Grandjean P; Guyton KZ; Hass U; Heindel JJ; Jobling S; Kidd KA; Kortenkamp A; Macleod MR; Martin OV; Norinder U; Scheringer M; Thayer KA; Toppari J; Whaley P; Woodruff TJ; Rudén C
Environ Health; 2016 Jul; 15(1):74. PubMed ID: 27412149
[TBL] [Abstract][Full Text] [Related]
9. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
[TBL] [Abstract][Full Text] [Related]
10. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology.
Vandenberg LN; Colborn T; Hayes TB; Heindel JJ; Jacobs DR; Lee DH; Myers JP; Shioda T; Soto AM; vom Saal FS; Welshons WV; Zoeller RT
Reprod Toxicol; 2013 Jul; 38():1-15. PubMed ID: 23411111
[TBL] [Abstract][Full Text] [Related]
11. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.
Smith CJ; Perfetti TA; Hayes AW; Berry SC
Regul Toxicol Pharmacol; 2020 Aug; 115():104711. PubMed ID: 32598900
[TBL] [Abstract][Full Text] [Related]
12. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol Lett; 2020 Oct; 331():259-264. PubMed ID: 32360654
[No Abstract] [Full Text] [Related]
13. Assessing dose-response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity.
Zoeller RT; Vandenberg LN
Environ Health; 2015 May; 14():42. PubMed ID: 25971795
[TBL] [Abstract][Full Text] [Related]
14. A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations.
Karthikeyan BS; Ravichandran J; Mohanraj K; Vivek-Ananth RP; Samal A
Sci Total Environ; 2019 Nov; 692():281-296. PubMed ID: 31349169
[TBL] [Abstract][Full Text] [Related]
15. Significance of and Challenges in Regulating Endocrine Disruptors - How Regulators and Industry Can Conquer?
Dhiman SK; Dureja H
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1664-1681. PubMed ID: 32504507
[TBL] [Abstract][Full Text] [Related]
16. Environmental epigenomics: Current approaches to assess epigenetic effects of endocrine disrupting compounds (EDC's) on human health.
Tapia-Orozco N; Santiago-Toledo G; Barrón V; Espinosa-García AM; García-García JA; García-Arrazola R
Environ Toxicol Pharmacol; 2017 Apr; 51():94-99. PubMed ID: 28215500
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of environmental endocrine disrupting chemicals.
Kuo CH; Yang SN; Kuo PL; Hung CH
Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
[TBL] [Abstract][Full Text] [Related]
18. Penile density and globally used chemicals in Canadian and Greenland polar bears.
Sonne C; Dyck M; Rigét FF; Beck Jensen JE; Hyldstrup L; Letcher RJ; Gustavson K; Gilbert MT; Dietz R
Environ Res; 2015 Feb; 137():287-91. PubMed ID: 25601730
[TBL] [Abstract][Full Text] [Related]
19. Endocrine disrupting chemicals: human exposure and health risks.
Yang M; Park MS; Lee HS
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2006; 24(2):183-224. PubMed ID: 17114110
[TBL] [Abstract][Full Text] [Related]
20. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.
Hotchkiss AK; Rider CV; Blystone CR; Wilson VS; Hartig PC; Ankley GT; Foster PM; Gray CL; Gray LE
Toxicol Sci; 2008 Oct; 105(2):235-59. PubMed ID: 18281716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
